BRENZAVVY proves effective in TheracosBio’s Phase 3 Type 2 diabetes study

TheracosBio announced the publication of a 24-week randomized, double-blind, placebo-controlled trial, proving Bexagliflozin's effectiveness as an adjunct to Metformin for treating adults with type 2 ... Read More